Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001172661-25-001228·AIM ImmunoTech Inc.
Schedule 13G ownership disclosure
AIM IMMUNOTECH INC
Common Stock, par value $0.001 per share · CUSIP: 00901B105
Event date: 2024-12-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Armistice Capital, LLC
Shares: 3,349,740.00 · Class: 4.99%
- Steven Boyd
Shares: 3,349,740.00 · Class: 4.99%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001172661-25-001228
- Form type
- SCHEDULE 13G/A
- Filer
- AIM ImmunoTech Inc.
- CIK
- CIK 946644
- Filed
- Feb 14, 2025
- Reporting period
- Dec 31, 2024
- Description
- Schedule 13G beneficial ownership